Pilot study on the efficacy and safety of generic mycophenolate mofetil (mycept) compared with cellcept among incident low-risk primary kidney transplant recipients

Transplantation Proceedings

Volumn 46, Issue 2, 2014, Pages 415-417

  Danguilan, R A ^a   Lamban, A B ^a   Luna, C A C ^a   Bacinillo, M ^a   Momongan, M I C ^a  

^a National Kidney and Transplant Institute Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

MYCEPT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; UNCLASSIFIED DRUG; GENERIC DRUG; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; BIOEQUIVALENCE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTOSIS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INFECTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LEUKOPENIA; LONG TERM CARE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MIDDLE AGED; PILOT STUDY; PRIORITY JOURNAL; THROMBOCYTOPENIA; TIME TO MAXIMUM PLASMA CONCENTRATION; YOUNG ADULT; AGED; ANALOGS AND DERIVATIVES; GLOMERULUS FILTRATION RATE; RISK ASSESSMENT; THERAPEUTIC EQUIVALENCE;

ADULT; AGED; AREA UNDER CURVE; DRUGS, GENERIC; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PILOT PROJECTS; RISK ASSESSMENT; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 84896459236     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.11.116     Document Type: Conference Paper

References (6)

1. D. Golshayan, M. Pascual, and B. Vogt Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability Ther Clin Risk Management 5 2009 341 351
2. Pollard, Nashan, and Johnston et al. A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A: a consensus statement Clin Ther 25 6 2003 1654 1669
3. Muller, Solari, and Zuniga et al. Immunosuppression with generic Tacrolimus and Mycophenolate in renal transplant recipients: preliminary report in Chile Transplant Proc 40 2008 705 707
4. S. Almeida, A. Filipe, and R. Neves et al. Mycophenolate mofetil 500 mg tablet under fasting conditions: a single-dose, randomized-sequence, open-label, four-way replicate cross-over, bioequivalence study in healthy subjects Clinical Therapeutics 32 2010 556 574
5. W. Yau, A. Vathsala, and H. Lou et al. Is a standard fixed dose of mycophenolate mofetil ideal for all patients? Nephrol Dial Transplant 22 2007 3638 3645
6. Y. Le Meur, M. Buchler, and A. Thierry Individualized mycophenolate dosing based on drug exposure significantly improves patient outcomes after renal transplantation Am J Transplant 7 2007 2496 2503